- Filed
- May 7, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 1, 2026 | 97.6M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 97.5M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 80.6M sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $0 |
| Stock Repurchased | Q1 2026 · Mar 31, 2025 | $1M |
| Capex | Q1 2026 · Mar 31, 2026 | $6M |
| Capex | Q1 2026 · Mar 31, 2025 | $12M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$30M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$38M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $108M |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $208M |
| Short Term Investments | Q1 2026 · Mar 31, 2026 | $59M |
| Short Term Investments | Q1 2026 · Dec 31, 2025 | $99M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $299M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $337M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $600M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $614M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $563M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $641M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $314M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $268M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $885M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $904M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $793M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $841M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $1.56B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $1.62B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.21 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.12 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.21 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.12 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $48M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $45M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $8M |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $9M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$16M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$7M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$1M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$13M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $57M |
| Gross Profit | Q1 2026 · Mar 31, 2025 | $46M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $208M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $201M |
| Revenue | Q1 2026 · Mar 31, 2026 | $265M |
| Revenue | Q1 2026 · Mar 31, 2025 | $247M |